HF
APGB.WS

HRT Financial’s Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share APGB.WS Stock Holding History

HRT Financial’s Portfolio APGB.WS Stock Details APGB.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-14,999
Closed -$1K – 3336
2023
Q3 		$1K Hold
14,999
– – ﹤0.01% 2308
2023
Q2 		$1K Buy
+14,999
New +$1.94K ﹤0.01% 2344

HRT Financial's APGB.WS Position: Q4 2023 in Review

HRT Financial sold out of Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share (APGB.WS) in Q4 2023, closing a stake of 14,999 shares — an estimated $1K sold.

HRT Financial first reported a position in APGB.WS in Q2 2023 and held it in 2 quarters. The position peaked at $1K in Q3 2023. 0 funds tracked by Wall St. Rank hold APGB.WS as of Q4 2023.

  • HRT Financial reported no remaining Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share position as of Q4 2023 after selling out during the quarter.
  • HRT Financial sold 14,999 Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share shares in Q4 2023, an estimated $1K.
  • HRT Financial first reported a position in Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share in Q2 2023 and held it in 2 quarters.
  • HRT Financial's Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share position peaked at $1K in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share as of Q4 2023.

Based on HRT Financial's 13F filing for Q4 2023, filed 9 Feb 2024.